First in human study of BAY2927088 in participants who have advanced non-small cell lung cancer (NSCLC) with mutations in the genes of epidermal growth factor receptor (EGFR) and/or human epidermal growth factor receptor 2 (HER2)

Status

Recruiting

Phases

Phase 1Phase 2

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2023-503795-24-00

Acronym

21607

Enrollment

120

Registered

2023-07-26

Start date

2022-09-16

Completion date

Unknown

Last updated

2025-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Avanced Non-Small Cell Lung Cancer

None listed

Sex/Gender

All

Age

18 Years to No maximum

Belgium, France, Italy, Netherlands, Poland, Portugal, Spain

None listed

Source: EU CTIS · Data processed: Feb 4, 2026